Shannon M Bloodworth

Shannon M. Bloodworth has extensive, policy-shaping litigation experience in pharmaceutical patents and representing clients before the Supreme Court of the United States, the U.S. Court of Appeals for the Federal Circuit, the Patent Trial and Appeal Board (PTAB), and numerous district courts, including the U.S. District Court for the District of Delaware, the U.S. District Court for the District of New Jersey, the U.S. District Court for the Southern District of New York, the U.S. District Court for the Northern District of West Virginia, and the U.S. District Court for the Western District of Wisconsin.

As lead trial counsel in several significant pharmaceutical patent litigations, Shannon won a milestone case for her client, Mylan Pharmaceuticals Inc., in the Federal Circuit that ended Mylan's high-stakes and long-running patent battle over a multiple sclerosis drug by proving patent invalidity. Shannon also secured a successful outcome for Mylan in a high-profile trial requiring PTAB to rule on whether the doctrine of tribal sovereign immunity applied to inter partes reviews. The Federal Circuit affirmed this industry-shaping decision.

She is recognized nationally for her trial work, including being ranked in Chambers USA for Intellectual Property: Litigation for six consecutive years.